Literature DB >> 18411014

Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review.

Nathan I Cherny1.   

Abstract

Diarrhea is a common and significant problem among patients with advanced cancer. Treatment-induced diarrhea can be severe and be associated with life-threatening dehydration and electrolyte abnormalities. The causes of diarrhea among patients with advanced cancer are diverse and some causes of diarrhea require specific therapies. Thus, careful evaluation of the underlying cause is necessary. Palliative care clinicians, particularly those dealing with patients receiving ongoing disease-modifying therapies, must be familiar with the common causes of diarrhea among cancer patients and the strategies to evaluate and manage these common and distressing symptoms. This article addresses four major issues: 1) a review of the causes of treatment-related diarrhea, focusing on diarrhea caused by chemotherapy, targeted therapies, and radiotherapy; 2) differential diagnosis and an approach to evaluation; 3) general management considerations; and 4) cause-specific issues in management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411014     DOI: 10.1016/j.jpainsymman.2007.10.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  9 in total

1.  Cryptosporidium gastroenteritis in Egyptian children with acute lymphoblastic leukemia: magnitude of the problem.

Authors:  S M A Hassanein; M M S Abd-El-Latif; O M Hassanin; L M S Abd-El-Latif; N I Ramadan
Journal:  Infection       Date:  2011-12-22       Impact factor: 3.553

2.  Irinotecan-induced intestinal mucositis in mice: a histopathological study.

Authors:  Thaise Boeing; Marcelo Biondaro Gois; Priscila de Souza; Lincon Bordignon Somensi; Débora de Mello Gonçales Sant Ana; Luisa Mota da Silva
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-31       Impact factor: 3.333

3.  A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer.

Authors:  Salvatore Artale; Nunziata Grillo; Stefano Lepori; Chiara Butti; Antonella Bovio; Sabrina Barzaghi; Andrea Colombo; Elena Castiglioni; Lucia Barbarini; Laura Zanlorenzi; Paola Antonelli; Riccardo Caccialanza; Paolo Pedrazzoli; Mauro Moroni; Sabrina Basciani; Rebecca Azzarello; Francesco Serra; Alessandra Trojani
Journal:  Nutrients       Date:  2022-04-26       Impact factor: 6.706

Review 4.  Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer.

Authors:  Kathleen N Moore; Bradley J Monk
Journal:  Oncologist       Date:  2016-06-02

5.  Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.

Authors:  Thaise Boeing; Priscila de Souza; Silvia Speca; Lincon Bordignon Somensi; Luisa Nathália Bolda Mariano; Benhur Judah Cury; Mariana Ferreira Dos Anjos; Nara Lins Meira Quintão; Laurent Dubuqoy; Pierre Desreumax; Luisa Mota da Silva; Sérgio Faloni de Andrade
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

Review 6.  Understanding and modulating mammalian-microbial communication for improved human health.

Authors:  Sridhar Mani; Urs A Boelsterli; Matthew R Redinbo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-23       Impact factor: 13.820

7.  Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2-3 diarrhoea.

Authors:  Tina Reis; Edwin Khazzaka; Grit Welzel; Frederik Wenz; Ralf-Dieter Hofheinz; Sabine Mai
Journal:  Radiat Oncol       Date:  2015-01-31       Impact factor: 3.481

8.  Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial.

Authors:  Joanne Mortimer; Jack Di Palma; Kendra Schmid; Yining Ye; Mohammad Jahanzeb
Journal:  Breast Cancer Res       Date:  2019-02-27       Impact factor: 6.466

Review 9.  Is There a Role for Bismuth in Diarrhea Management?

Authors:  Helen Senderovich; Megan Vierhout
Journal:  Rambam Maimonides Med J       Date:  2021-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.